Acutus Medical, Inc. (AFIB)
USD 0.03
(6.67%)
USD 0.03
(6.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -3.13 Million USD | 79.82% |
| 2022 | -15.54 Million USD | 0.73% |
| 2021 | -15.66 Million USD | -110.94% |
| 2020 | -7.42 Million USD | -15.89% |
| 2019 | -6.4 Million USD | -19.89% |
| 2018 | -5.34 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -343 Thousand USD | -1043.33% |
| 2024 Q1 | -30 Thousand USD | -100.53% |
| 2023 Q1 | -2.62 Million USD | 22.0% |
| 2023 FY | -3.13 Million USD | 79.82% |
| 2023 Q3 | -3.35 Million USD | -21.02% |
| 2023 Q2 | -2.77 Million USD | -5.88% |
| 2023 Q4 | 5.61 Million USD | 267.23% |
| 2022 Q3 | -3.3 Million USD | 41.17% |
| 2022 Q2 | -5.62 Million USD | -72.42% |
| 2022 Q1 | -3.26 Million USD | 41.55% |
| 2022 FY | -15.54 Million USD | 0.73% |
| 2022 Q4 | -3.35 Million USD | -1.57% |
| 2021 FY | -15.66 Million USD | -110.94% |
| 2021 Q3 | -3.93 Million USD | -41.5% |
| 2021 Q4 | -5.57 Million USD | -41.62% |
| 2021 Q2 | -2.78 Million USD | 17.27% |
| 2021 Q1 | -3.36 Million USD | -45.19% |
| 2020 Q3 | -1.96 Million USD | -28.71% |
| 2020 Q2 | -1.52 Million USD | 5.09% |
| 2020 Q1 | -1.61 Million USD | 5.01% |
| 2020 FY | -7.42 Million USD | -15.89% |
| 2020 Q4 | -2.31 Million USD | -17.73% |
| 2019 Q1 | -1.38 Million USD | 0.0% |
| 2019 FY | -6.4 Million USD | -19.89% |
| 2019 Q4 | -1.69 Million USD | -4.63% |
| 2019 Q3 | -1.62 Million USD | 4.7% |
| 2019 Q2 | -1.7 Million USD | -22.46% |
| 2018 FY | -5.34 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Biotricity, Inc. | 8.35 Million USD | 137.541% |
| Cell MedX Corp. | - USD | Infinity% |
| Dynatronics Corporation | 7.63 Million USD | 141.087% |
| Nemaura Medical Inc. | -1.47 Million USD | -112.477% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 524.191% |
| RetinalGenix Technologies Inc. | -100.00 USD | -3136900.0% |
| Sonendo, Inc. | 10.72 Million USD | 129.258% |
| Telesis Bio, Inc. | 16.95 Million USD | 118.507% |
| Talis Biomedical Corporation | 371 Thousand USD | 945.553% |
| Viveve Medical, Inc. | 620 Thousand USD | 605.968% |